GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » EV-to-Revenue

SciBase Holding AB (OSTO:SCIB) EV-to-Revenue : 2.01 (As of Jun. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SciBase Holding AB's enterprise value is kr48.64 Mil. SciBase Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr24.15 Mil. Therefore, SciBase Holding AB's EV-to-Revenue for today is 2.01.

The historical rank and industry rank for SciBase Holding AB's EV-to-Revenue or its related term are showing as below:

OSTO:SCIB' s EV-to-Revenue Range Over the Past 10 Years
Min: -6.38   Med: 11.36   Max: 195.78
Current: 2.01

During the past 11 years, the highest EV-to-Revenue of SciBase Holding AB was 195.78. The lowest was -6.38. And the median was 11.36.

OSTO:SCIB's EV-to-Revenue is ranked better than
67.52% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.06 vs OSTO:SCIB: 2.01

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-19), SciBase Holding AB's stock price is kr0.346. SciBase Holding AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.23. Therefore, SciBase Holding AB's PS Ratio for today is 1.51.


SciBase Holding AB EV-to-Revenue Historical Data

The historical data trend for SciBase Holding AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciBase Holding AB EV-to-Revenue Chart

SciBase Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.18 22.61 26.88 14.02 3.12

SciBase Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.71 3.55 4.27 3.12 1.10

Competitive Comparison of SciBase Holding AB's EV-to-Revenue

For the Medical Devices subindustry, SciBase Holding AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's EV-to-Revenue falls into.



SciBase Holding AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

SciBase Holding AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=48.636/24.154
=2.01

SciBase Holding AB's current Enterprise Value is kr48.64 Mil.
SciBase Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr24.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciBase Holding AB  (OSTO:SCIB) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

SciBase Holding AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.346/0.229
=1.51

SciBase Holding AB's share price for today is kr0.346.
SciBase Holding AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.23.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciBase Holding AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of SciBase Holding AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SciBase Holding AB (OSTO:SCIB) Business Description

Traded in Other Exchanges
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments: skin cancer and skin barrier assessment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB (OSTO:SCIB) Headlines

No Headlines